Diagnosis of Portal Hypertension

Søren Møller1,2, Karen V Danielsen1,3, Lise Hobolth3

  • 1Department of Clinical Physiology and Nuclear Medicine, Center for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, DK-2650 Hvidovre, Denmark.

PubMed

Insights

Chronic liver disease causes portal hypertension, a condition best assessed by hepatic venous pressure gradient (HVPG) measurement. HVPG guides diagnosis, prognosis, and treatment, crucial for managing this global health issue.

Area of Science:

  • Hepatology
  • Cardiovascular Medicine
  • Gastroenterology

Background:

  • Chronic liver disease (CLD) presents a significant global health challenge.
  • Portal hypertension (PH) and its complications arise from complex pathophysiological mechanisms within the liver.
  • Effective management of CLD and PH necessitates a thorough understanding of these underlying processes.

Purpose of the Study:

  • To review the comprehensive management of patients suffering from portal hypertension (PH).
  • To highlight the critical indications for measuring the hepatic venous pressure gradient (HVPG) in PH patients.
  • To emphasize the role of HVPG in diagnosis, prognosis, and guiding therapy for PH.

Main Methods:

  • This review synthesizes current knowledge on PH management.
  • It focuses on the diagnostic and prognostic utility of the hepatic venous pressure gradient (HVPG).
  • The role of non-invasive tests is discussed in comparison to HVPG.

Main Results:

  • The hepatic venous pressure gradient (HVPG) is the gold standard for assessing PH severity and guiding treatment.
  • HVPG measurement provides essential prognostic information and helps determine the need for pharmacological interventions.
  • Reductions in HVPG correlate with improved patient outcomes.
  • Non-invasive methods are valuable but do not fully replace HVPG for precise assessment.

Conclusions:

  • Accurate assessment of portal hypertension through HVPG measurement is vital for effective patient management.
  • HVPG guides therapeutic decisions, including the initiation and monitoring of treatments like beta-blockers.
  • Understanding HVPG's role is crucial for improving outcomes in patients with chronic liver disease and PH.

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
355
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.2K
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.1K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
522
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
2.6K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
171